Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.83)
# 82
Out of 5,147 analysts
41
Total ratings
71.11%
Success rate
41.49%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRXS NeurAxis | Maintains: Buy | $7 → $8 | $6.00 | +33.33% | 2 | Dec 22, 2025 | |
| HROW Harrow | Maintains: Buy | $54 → $64 | $54.18 | +18.12% | 4 | Sep 23, 2025 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $13 → $14 | $8.49 | +64.90% | 6 | Aug 15, 2025 | |
| PYPD PolyPid | Maintains: Buy | $15 → $13 | $4.25 | +205.88% | 2 | Aug 14, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $6.5 → $11 | $6.12 | +79.74% | 2 | Aug 8, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $8 → $11 | $7.95 | +38.36% | 1 | Jul 18, 2025 | |
| BFLY Butterfly Network | Initiates: Buy | $3 | $3.79 | -20.84% | 1 | Jul 1, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $12 → $17 | $12.56 | +35.35% | 3 | Jun 9, 2025 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $28 | $16.99 | +64.80% | 6 | May 14, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $17.30 | +125.43% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.42 | +133.92% | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $21 | $8.90 | +135.96% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $4.77 | +25.79% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $4.89 | +145.40% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.10 | +23.46% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.57 | +110.42% | 2 | Jul 11, 2023 |
NeurAxis
Dec 22, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $6.00
Upside: +33.33%
Harrow
Sep 23, 2025
Maintains: Buy
Price Target: $54 → $64
Current: $54.18
Upside: +18.12%
Fennec Pharmaceuticals
Aug 15, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $8.49
Upside: +64.90%
PolyPid
Aug 14, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $4.25
Upside: +205.88%
Xeris Biopharma Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $6.5 → $11
Current: $6.12
Upside: +79.74%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $7.95
Upside: +38.36%
Butterfly Network
Jul 1, 2025
Initiates: Buy
Price Target: $3
Current: $3.79
Upside: -20.84%
Phathom Pharmaceuticals
Jun 9, 2025
Maintains: Buy
Price Target: $12 → $17
Current: $12.56
Upside: +35.35%
Eton Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $26 → $28
Current: $16.99
Upside: +64.80%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $17.30
Upside: +125.43%
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.42
Upside: +133.92%
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $8.90
Upside: +135.96%
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $4.77
Upside: +25.79%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $4.89
Upside: +145.40%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $8.10
Upside: +23.46%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.57
Upside: +110.42%